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In this issue of Cell Stem Cell, Crisan et al. (2008) document a subpopulation of human perivascular cells that
express both pericyte andmesenchymal stem cell (MSC)markers in situ. The isolated population can expand
and is clonally multipotent in culture, establishing that MSCs found throughout fetal and adult tissues are
members of the pericyte family of cells.The publication by Crisan et al. (2008) is
a landmark paper which presents a large
body of work that defines, refines, con-
firms, establishes, and validates both the
in situ and in vitro links between adult hu-
manmesenchymal stem cells (MSCs) and
perivascular cells, summarily referred to
here as pericytes. A 20 member interna-
tional team from two clinical departments,
two institutes, and two centers, the Stem
Cell Research Center and the Cell Factory
(a harbinger of the next generation of
mass-produced cell-based therapies?)
was coordinated by the senior author,
Bruno Pe´ault, in Pittsburgh. The impor-
tance of this contribution is that it brings
together a large body of previous re-
search to directly compare the in vivo lo-
cation and cell marker signatures of two
important cell types, the MSC and the
pericyte, and documents their identity.
The observations clearly show that cells
with MSC markers also express pericyte
markers; this result allows me to provoca-
tively speculate that all MSCs are peri-
cytes. This relationship is further empha-
sized by using cell sorting for pericytes
(CD146+, CD34, CD45, CD56) and
subsequent in vitro expansion to docu-
ment that the sorted cells or clones are
multipotent for osteogenic, chondro-
genic, adipogenic, and myogenic line-
ages in vitro, which are hallmarks of
MSC identity (Caplan, 2007). The experi-
ments examine many organs and tissues
from multiple fetal and adult donors. The
group is expert in myogenesis, so there
is considerable focus on whether satellite
cells (committed myogenic precursors)
are distinct from the pericyte population.
Indeed, pericytes exhibit distinct pheno-
typic and functional traits from satellite
cells across the entire range of tissues ex-
amined (Crisan et al., 2008). Although not
commented upon, I suspect that the cellsfrom fetal tissues and older adult tissues
gave different quantitative results in the
in vitro expansion and differentiation as-
says. That said, it must be stated that
the function of MSCs/pericytes is antici-
pated to be quite different in developing
tissues compared to their predicted role
in the homeostasis of adult tissue. Last,
the MSCs/pericytes do not form tera-
tomas, and their differentiation spectrum
seems to be limited; thus, this cell popula-
tion is distinct from embryonic stem cells.
In regard to the in situ function of peri-
cytes, there are several open questions:
do MSCs/pericytes respond to vasoactive
drugs that regulate blood flow and pres-
sure? Do pericytes directly contribute to
tissue repair/regeneration by differentia-
tion into mesenchymal phenotypes such
as osteoblasts, adipocytes, myoblasts,
etc.? Do pericytes have other functions?
Pe´ault and his collaborators clearly state
and document that the pericytes do not dif-
ferentiate into hematopoietic or neural phe-
notypes in adults, yet the vascular/perivas-
cular location of hematopoietic and neural
stem cells in early fetal tissue (Kiel et al.,
2005; Hirshi and D’Amore, 1996) implies
thatotherstemcells inhabit theperivascular
niche. This observation also clearly docu-
ments that not all pericytes are MSCs.
With regard to the response to focal in-
jury, I envision two quite different pericyte
functions: as suggested by Brighton et al.
(1992) and others in the 1980s and 1990s,
the healing of broken bones (i.e., callus
formation) clearly involves the osteochon-
drogenic properties of local MSCs/peri-
cytes. In addition, the endochondral re-
placement of cartilage by vasculature
would bring MSCs/pericytes into both
embryonic and adult tissue fields that
could directly differentiate into vascular-
driven bone in both orthotopic (Caplan
and Pechak, 1987) and heterotopic loca-Cell Stem Cell 3, Stions (Caplan, 1990). This model is in
keeping with the differentiation-focused
discussion of Crisan et al. (2008).
A second function of the MSC/pericyte
in settings of focal injury has recently been
outlined by my colleagues and me (da
Silva Meirelles et al., 2008) and focuses
on the fact that MSCs secrete huge
amounts of bioactive molecules that con-
tribute to immunomodulatory functions
and, separately, offer so-called ‘‘trophic
activities’’ by structuring a regenerative
microenvironment (Dennis and Caplan,
1997). An important aspect of this com-
plex secretory capacity of MSCs is that
Crisan et al. (2008) have documented
that MSCs/pericytes migrate in response
to digested ECM and other chemotactic
stimuli, which could recruit MSCs from
both local and surrounding sites to the
focal injury. The fabrication of certain bio-
active molecules by the MSCs inhibits
T cells by affecting antigen presentation
and T cell progenitor expansion. This im-
munomodulatory activity will protect the
injury site from immune surveillance and,
thus, forestall autoimmunity sensitization
to the damaged tissue. Also, by dampen-
ing chronic inflammatory activity, the acti-
vated MSCs will inhibit apoptosis due, in
part, to ischemia; inhibit the entrance or
formation of myofibroblasts and, thus, in-
hibit scar formation; stimulate the mitosis
of tissue-intrinsic progenitors whose
progeny reform the damaged tissue;
and, by reassuming their pericyte function
and locations, may stimulate and stabilize
angiogenesis and vessel reformation.
Are all MSCs pericytes? Certainly, all
pericytes are not MSCs, since both large
and small vessels are surrounded by peri-
vascular cells with highly differentiated
functions quite separate from the activi-
ties associated with the osteo-, chon-
dro-, or adipogenic progeny of MSCs. Ineptember 11, 2008 ª2008 Elsevier Inc. 229
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neural or hematopoietic stem cells, ap-
pear to reside in perivascular locations
in situ (Hirshi and D’Amore, 1996). Since
MSCs isolated from different tissues ex-
hibit distinct sensitivities to inductive bio-
active molecules in culture, it follows that
this reactivity reflects the tissue of origin.
Most well studied are the adult marrow-
derived MSCs, which are often used as
the standard. The inductive conditions for
marrow MSCs are quite different from
those requiredby fat-derivedMSCs (Estes
etal., 2006),asmaybeexpecteddue to the
diversemicroenvironments present on the
tissue side of the vasculature in which the
pericytes reside. The MSCs from marrow
and fat arebothmultipotent, but the induc-
tive stimulus, TGF-b, for chondrogenesis
for marrow MSCs must be supplemented
with BMP-6 for fat MSCs. Clearly, such
variation in inductive requirements must
be taken into account when designing
expansion and differentiation protocols
for use in future therapeutic applications.The Center of the
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cells may facilitate repair of the inju
Repair of the injured spinal cord is one of
the ‘‘holy grails’’ of medicine. The devel-
opment of strategies to protect and repair
the injured spinal cord has been facilitated
by the identification of key mechanisms of
secondary injury, by the characterization
of extrinsic barriers to axonal regenera-
tion, and by the discovery of neural stem
cells within the adult central nervous sys-
tem (CNS) (Rossignol et al., 2007).
230 Cell Stem Cell 3, September 11, 2008 ªAlthough my colleagues and I have
been working with marrow MSCs for
over 20 years and have published on
markers of MSCs, their perivascular local-
ization in human skin, their multipotency,
and their secretion of bioactive factors
(Caplan, 2007), we and others have never
performed a comprehensive and detailed
comparison of the in situ and in vitro traits
of MSCs and pericytes. The team led by
Bruno Pe´ault provides a solid set of ob-
servations that clearly links the MSC and
pericyte. There will be a number of excep-
tions, but my suggestion is that all MSCs
are pericytes, and this manuscript gives
a formal context to better understand, in
both embryos and adults, how the MSC/
pericyte contributes to the formation,
maturation, and homeostasis of all vascu-
larized tissues.
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Neural precursor cells are emerging
as another potential means to repair the
injured CNS (Karimi-Abdolrezaee et al.,
2006). The precise source(s) of endoge-
nous neural precursor cells has been
controversial; however, in the brain, evi-
dence supports a role for cells in both
